Golden
Renew BioPharma

Renew BioPharma

Renew Biopharma is a synthetic biology company that develops therapeutics targeting pain management, neurodegenerative diseases, and traumatic brain injuries using cannabinoids.

Renew Biopharma is a Delaware C Corporation based in San Diego, California, that was founded in 2017 by Michael Mendez. Michael Mendez is also the CEO of Renew BioPharma with more than 20 years of experience working in the synthetic biology industry. The company is focused on creating a pipeline of 100 percent pure, uncontaminated and non-psychoactive cannabinoids in quantities large enough to enable human therapeutic treatments. Renew uses molecular biology and pathway engineering instead of using agriculturally-grown Cannabis plants. Renew has a proprietary family of pharmacological chemical compounds - cannabinoids - specifically pure forms of CBG (cannabigerol) and CBD (cannabidiol). Renew's intellectual property includes both specific genes in the biosynthesis of cannabinoids and the ability to engineer a synthetic cannabinoid pathway into microorganisms, including microalgae.

Renew BioPharma possesses intellectual property and technological capabilities related to engineering enzymes for creating proprietary derivative molecules for the development of pharmaceutical drugs.

Timeline

2016

Renew BioPharma was founded.

People

Name
Role
LinkedIn

Michael Mendez

CEO

Further reading

Title
Author
Link
Type
Date

Renew Biopharma Launches Pre-Clinical Drug Discovery Program with Indiana University Bloomington's Gill Center for Biomolecular Science Using Cannabinoids Grown in Microalgae

Business Wire

Web

Documentaries, videos and podcasts

Title
Date
Link

Renew Biopharma

October 29, 2018

Companies

Company
CEO
Location
Products/Services
+ Add new row

References